VCAM1 and neoplasm: This review thereby details the adhesive mechanisms of VCAM-1 in colorectal disease—specifically, driving immune cell infiltration during IBD and tumour cell metastasis in CRC—and posits the potential of this receptor as a common drug target for both diseases.